As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/26/18  Nymox Pharmaceutical Corp         6-K        11/23/18    4:149K                                   e3 Fil… Computershare/FA

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Report of Foreign Issuer for November 2018          HTML      8K 
 2: EX-99.1     Notice of Annual General Meeting on December 18,    HTML      7K 
                          2018                                                   
 3: EX-99.2     Information Circular                                HTML     70K 
 4: EX-99.3     Form of Proxy                                       HTML     22K 

FORM 6-K

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934

For the period ended November 23, 2018

Commission File Number: 001-12033

Nymox Pharmaceutical Corporation

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F [ X ] Form 40-F [   ]

Indicate by check mark if the registrant is submitting Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(l): [   ]

Indicate by check mark if the registrant is submitting Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [   ]

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes [   ] No [ X ]

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-______________

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 23, 2018